AP9901518A0 - Methods and compositions for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors. - Google Patents

Methods and compositions for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors.

Info

Publication number
AP9901518A0
AP9901518A0 APAP/P/1999/001518A AP9901518A AP9901518A0 AP 9901518 A0 AP9901518 A0 AP 9901518A0 AP 9901518 A AP9901518 A AP 9901518A AP 9901518 A0 AP9901518 A0 AP 9901518A0
Authority
AP
ARIPO
Prior art keywords
methods
compositions
fkbp12
affinity
compounds
Prior art date
Application number
APAP/P/1999/001518A
Other languages
English (en)
Inventor
Robert E Zelle
Michael Su
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25009484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP9901518(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of AP9901518A0 publication Critical patent/AP9901518A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
APAP/P/1999/001518A 1996-11-13 1997-11-13 Methods and compositions for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors. AP9901518A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/748,447 US5840736A (en) 1996-11-13 1996-11-13 Methods and compositions for stimulating neurite growth
PCT/US1997/020866 WO1998020891A1 (en) 1996-11-13 1997-11-13 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors

Publications (1)

Publication Number Publication Date
AP9901518A0 true AP9901518A0 (en) 1999-06-30

Family

ID=25009484

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1999/001518A AP9901518A0 (en) 1996-11-13 1997-11-13 Methods and compositions for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors.

Country Status (32)

Country Link
US (3) US5840736A (cg-RX-API-DMAC7.html)
EP (1) EP0946190B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001504470A (cg-RX-API-DMAC7.html)
KR (1) KR100544451B1 (cg-RX-API-DMAC7.html)
CN (1) CN1168442C (cg-RX-API-DMAC7.html)
AP (1) AP9901518A0 (cg-RX-API-DMAC7.html)
AR (1) AR011278A1 (cg-RX-API-DMAC7.html)
AT (1) ATE250424T1 (cg-RX-API-DMAC7.html)
AU (1) AU724833B2 (cg-RX-API-DMAC7.html)
BG (1) BG64670B1 (cg-RX-API-DMAC7.html)
BR (1) BR9712765A (cg-RX-API-DMAC7.html)
CA (1) CA2270634A1 (cg-RX-API-DMAC7.html)
CO (1) CO4930260A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ296058B6 (cg-RX-API-DMAC7.html)
DE (1) DE69725169T2 (cg-RX-API-DMAC7.html)
DK (1) DK0946190T3 (cg-RX-API-DMAC7.html)
EA (1) EA004247B1 (cg-RX-API-DMAC7.html)
ES (1) ES2206753T3 (cg-RX-API-DMAC7.html)
HU (1) HU226728B1 (cg-RX-API-DMAC7.html)
IL (1) IL129555A (cg-RX-API-DMAC7.html)
IN (1) IN183740B (cg-RX-API-DMAC7.html)
IS (1) IS2057B (cg-RX-API-DMAC7.html)
NO (1) NO328030B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ335394A (cg-RX-API-DMAC7.html)
PL (1) PL190903B1 (cg-RX-API-DMAC7.html)
PT (1) PT946190E (cg-RX-API-DMAC7.html)
SK (1) SK284535B6 (cg-RX-API-DMAC7.html)
TR (1) TR199901034T2 (cg-RX-API-DMAC7.html)
TW (1) TW513302B (cg-RX-API-DMAC7.html)
UA (1) UA63926C2 (cg-RX-API-DMAC7.html)
WO (1) WO1998020891A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA9710256B (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US6242468B1 (en) 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
US6514686B2 (en) 1997-04-28 2003-02-04 The University Of British Columbia Method and composition for modulating amyloidosis
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US5968921A (en) * 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
US7459473B2 (en) 1998-06-03 2008-12-02 Glia Med, Inc. N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
AP2001002052A0 (en) 1998-07-17 2001-03-31 Agouron Pharma Compounds, compositions, and methods for stimulating neuronal growth and elongation
GB9815880D0 (en) 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6228872B1 (en) * 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
EP1135105B1 (en) * 1998-12-09 2005-03-02 Chiron Corporation Use of a neurologic agent for the manufacture of a medicament for the treatment of a central nervous system disorder
EP1140844A1 (en) * 1999-01-08 2001-10-10 Vertex Pharmaceuticals Incorporated Process for the formation of intermediates useful for the preparation of pharmaceuticals
AU6073300A (en) * 1999-07-06 2001-01-22 Vertex Pharmaceuticals Incorporated N-heterocyclic derivatives with neuronal activity
US6734211B1 (en) * 1999-07-09 2004-05-11 Oregon Health & Sciences University Compositions and methods for promoting nerve regeneration
EP1207882A4 (en) * 1999-07-30 2003-03-19 Vertex Pharma DERIVATIVES OF ACYCLIC AND CYCLIC AMINES
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
JP2003514015A (ja) * 1999-11-12 2003-04-15 アルコン，インコーポレイテッド 眼の状態を処置するためのニューロフィリンリガンド
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
US7060676B2 (en) * 1999-12-20 2006-06-13 Trustees Of Tufts College T. cruzi-derived neurotrophic agents and methods of use therefor
ATE319712T1 (de) 1999-12-21 2006-03-15 Mgi Gp Inc Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
CA2447986A1 (en) * 2001-05-25 2002-12-05 Cornell Research Foundation, Inc. High affinity ligand for p75 neurotrophin receptor
FR2825273B1 (fr) * 2001-05-29 2006-11-24 Oreal Composition pour le traitement des signes cutanes du vieillissement
MXPA03011095A (es) * 2001-05-29 2005-04-28 Guilford Pharm Inc Metodo para tratar una lesion nerviosa causada por cirugia.
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US7232798B2 (en) 2001-11-13 2007-06-19 Tran Loi H Neuroprotection and neuroegenisis by administering cyclic prolyl glycine
US20100247483A1 (en) * 2001-11-13 2010-09-30 Tran Loi H Therapeutic agent composition and method of use
CA2466701C (en) * 2001-11-13 2013-11-12 Loi Tran Neuroprotective use of cyclic prolyl glycine
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
DOP2007000021A (es) * 2006-02-02 2007-08-31 Rinat Neuroscience Corp Procedimientos para tratar pérdida de peso no deseada o trastornos alimentarios administrando un agonista de trkb
JP2009525319A (ja) * 2006-02-02 2009-07-09 ライナット ニューロサイエンス コーポレイション ｔｒｋＢアンタゴニストを投与することにより肥満を治療する方法
WO2008078179A1 (en) * 2006-12-20 2008-07-03 Rinat Neuroscience Corporation Trkb agonists for treating autoimmune disorders
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
AU2019271189A1 (en) 2018-05-15 2021-01-07 Lloyd Hung Loi TRAN Therapeutic agent composition and method of use, for treatment of mild cognitive impairment, depression, and psychological disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US6037370A (en) * 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5811434A (en) * 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
US9604852B2 (en) * 2012-09-28 2017-03-28 Dic Corporation α-alumina particles and method for manufacturing the same

Also Published As

Publication number Publication date
ATE250424T1 (de) 2003-10-15
PL190903B1 (pl) 2006-02-28
JP2001504470A (ja) 2001-04-03
PL333270A1 (en) 1999-11-22
CO4930260A1 (es) 2000-06-27
US6172086B1 (en) 2001-01-09
CN1168442C (zh) 2004-09-29
ES2206753T3 (es) 2004-05-16
CZ168399A3 (cs) 1999-08-11
DE69725169T2 (de) 2004-07-15
HUP0001219A2 (hu) 2000-11-28
HU226728B1 (en) 2009-08-28
US5840736A (en) 1998-11-24
HK1022851A1 (en) 2000-08-25
EA004247B1 (ru) 2004-02-26
CA2270634A1 (en) 1998-05-22
CZ296058B6 (cs) 2006-01-11
ZA9710256B (en) 1998-05-28
EA199900464A1 (ru) 2000-02-28
NZ335394A (en) 2000-06-23
DE69725169D1 (de) 2003-10-30
KR20000068962A (ko) 2000-11-25
PT946190E (pt) 2004-02-27
IN183740B (cg-RX-API-DMAC7.html) 2000-04-01
HUP0001219A3 (en) 2001-12-28
AU5258998A (en) 1998-06-03
NO992138D0 (no) 1999-05-03
EP0946190A1 (en) 1999-10-06
BR9712765A (pt) 1999-10-26
IS2057B (is) 2005-10-14
TW513302B (en) 2002-12-11
UA63926C2 (uk) 2004-02-16
US6284778B1 (en) 2001-09-04
EP0946190B1 (en) 2003-09-24
BG103429A (en) 2000-04-28
CN1239433A (zh) 1999-12-22
SK62899A3 (en) 2000-04-10
AR011278A1 (es) 2000-08-16
IL129555A (en) 2005-08-31
DK0946190T3 (da) 2003-12-08
AU724833B2 (en) 2000-09-28
NO328030B1 (no) 2009-11-16
KR100544451B1 (ko) 2006-01-24
BG64670B1 (bg) 2005-11-30
IS5032A (is) 1999-04-21
WO1998020891A1 (en) 1998-05-22
SK284535B6 (sk) 2005-06-02
TR199901034T2 (xx) 1999-07-21
NO992138L (no) 1999-07-13
IL129555A0 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
AP9901518A0 (en) Methods and compositions for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors.
ZA964852B (en) Methods and compositions for stimulating neurite growth
BR9713037A (pt) Métodos e composições para estimulação do crescimento de neurites utilizando compostos com afinidade para fkbp12 em combinação com fatores neurotróficos
BR9712947A (pt) Processo e composições para a estimulação do crescimento de neuritos.
MXPA02005510A (es) Compuestos, composiciones y metodos para estimular el crecimiento y alargamiento neuronal.
AU8163398A (en) Inhibitors of alpha4beta1mediated cell adhesion
CA2248139A1 (en) Methods of alleviating neuropathic pain using prosaposin-derived peptides
GR3021087T3 (en) Compositions for treating ischemia-related neuronal damage.
PL320484A1 (en) Method of treating diabetes using kgf
BR9811923A (pt) Compostos possuindo atividade neuronal
EP0388226A3 (en) Means for the treatment of senile dementia, memory disorders and related conditions
MX9709829A (es) Metodos y composiciones para estimular el crecimiento de neurita.
CA2469779A1 (en) Method for the treatment of bone disorders
AP2001002052A0 (en) Compounds, compositions, and methods for stimulating neuronal growth and elongation
ES2117717T3 (es) Tratamiento de tumores con factores neurotroficos e inhibidores de la proliferacion celular.
DE69322226D1 (de) Integriertes Dünnschichtverfahren zur Erlangung von hohen Ballastwerten für Überlagerungsstrukturen
ZA959834B (en) Heterocyclic compounds and their preparation and use
WO2000012690A3 (en) Laminin 5 for treatment of bone defects